Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2023-04-27 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房2022年度审计报告
Regulatory Filings
2023-04-27 Chinese
益丰药房关于召开2022年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a notice about the convening of the 2022 Annual General Meeting (AGM) of the company, including details such as the date, voting methods, agenda items, and instructions for shareholders. It does not contain the actual annual report or financial statements but rather information about the meeting where such reports will be discussed and voted on. The document length is 3290 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2023-04-27 Chinese
益丰药房第四届董事会第二十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 24th meeting of the 4th Board of Directors of Yifeng Pharmacy Chain Co., Ltd. It includes multiple agenda items such as approval of the 2022 annual reports, financial statements, audit reports, social responsibility report, profit distribution plan, appointment of auditors, internal control evaluation, and other corporate governance matters. The document references the need to submit these items to the shareholders' meeting for approval and provides voting results for each agenda item. It also mentions the upcoming 2022 annual shareholders' meeting and the related proposals to be considered there. The document is not the annual report itself but a board meeting resolution announcement covering various reports and proposals related to the annual report and other corporate governance matters. This fits the definition of Board/Management Information (MANG), which includes announcements of changes or decisions by the board of directors. The document length (8521 characters) and content confirm it is not a brief announcement or a report publication announcement but a substantive board meeting resolution announcement.
2023-04-27 Chinese
益丰药房2022年度内部控制审计报告
Regulatory Filings
2023-04-27 Chinese
益丰药房2022年度社会责任报告
Environmental & Social Information Classification · 100% confidence The document is titled '2022 年度社会责任报告' which translates to '2022 Annual Social Responsibility Report'. It covers topics such as company governance, environmental protection, employee care, supplier and consumer rights protection, and social contributions. The content is focused on Environmental, Social, and Governance (ESG) factors and corporate social responsibility activities. There is no indication that this is a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it an announcement or a transcript. The length is substantial (over 14,000 characters) and contains detailed narrative and data about social responsibility performance. Therefore, the document fits the category of Environmental & Social Information (SR).
2023-04-27 Chinese
益丰药房关于2022年日常关联交易确认及2023年日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Yifeng Pharmacy Chain Co., Ltd. regarding the confirmation of daily related party transactions for the period September to December 2022 and the forecast of such transactions for 2023. It includes details about the amounts involved, the nature of the transactions, the related parties, and the board's approval process. The document is a formal disclosure about related party transactions, which is a regulatory announcement to inform shareholders and the market about these transactions and their compliance with fairness and independence principles. It does not contain financial statements, audit opinions, or detailed financial results. It is not a full annual or interim report, nor is it a call transcript or management discussion. The document is relatively short (4062 characters) and serves as a regulatory announcement about related party transactions. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-04-27 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.